These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4412195)

  • 1. Bio-availability of INH in liquid dosage form.
    Chavan SR; Nikam ST; Pradhan DV; Bhide MB; Gaitonde BB
    Indian J Physiol Pharmacol; 1974; 18(2):120-2. PubMed ID: 4412195
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biologic availability as a function of the pharmaceutic form].
    Cardini C; Mazzaracchio F; Quercia V
    Boll Chim Farm; 1974 Aug; 113(8):455-7. PubMed ID: 4433431
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioavailability study with a new isoniazid preparation.
    Eidus L; Hodgkin MM; Hsu AH
    Int J Clin Pharmacol; 1973 Oct; 8(2):154-9. PubMed ID: 4762906
    [No Abstract]   [Full Text] [Related]  

  • 4. [Basic studies on the isoniazid (INH) therapy. 3. Decomposition of the INH derivatives and intestinal absorption].
    Okudaira M; Kuchii M; Shimizu Y
    Iryo; 1969 Dec; 23(12):1511-6. PubMed ID: 5382110
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of the availability of six commercial formulations of isoniazid.
    Gelber R; Jacobsen P; Levy L
    Clin Pharmacol Ther; 1969; 10(6):841-8. PubMed ID: 5349625
    [No Abstract]   [Full Text] [Related]  

  • 6. Isoniazid and ethionamide serum levels and inactivation in Finnish subjects.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(2):110-24. PubMed ID: 5195839
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the dissolution test of the solid dosage form. I. Correlation of bioavailability and dissolution rate of isonicotinic acid hydrazide tablet (author's transl)].
    Ogata H; Suzuki S; Shibazaki T; Ejima A; Inoue T
    Yakugaku Zasshi; 1978 Jul; 98(7):823-31. PubMed ID: 712546
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of pyrazinamide and rifampicin on isoniazid metabolism in rats.
    De Rosa HJ; Baldan HM; Brunetti IL; Ximenes VF; Machado RG
    Biopharm Drug Dispos; 2007 Sep; 28(6):291-6. PubMed ID: 17571294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of biologic availability of active principles contained in galenic forms for cutaneous administration].
    Aiache JM; Aiache S; Guilpain G; Paire M
    Boll Chim Farm; 1977 Feb; 116(2):63-80. PubMed ID: 861080
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers.
    Padgaonkar KA; Revankar SN; Bhatt AD; Vaz JA; Desai ND; D'Sa S; Shah V; Gandewar K
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):627-31. PubMed ID: 10423226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percentage ratio of free- and acetyl-INH in the urine as a method of determination of the INH inactivation pattern].
    Rózniecki J
    Gruzlica; 1968 Oct; 36(10):971-3. PubMed ID: 5715459
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tracheobronchial administration of isoniazid after preliminary inhalation anesthesia].
    Savula MM; Piatnochka IT; Rybak LD
    Probl Tuberk; 1980 Jul; (7):30-3. PubMed ID: 7413631
    [No Abstract]   [Full Text] [Related]  

  • 13. [Kinetics of isoniazid metabolism after intravenous administration].
    Stepanov VM
    Probl Tuberk; 1981 Aug; (8):66-9. PubMed ID: 7291181
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoniazid inactivation in Finns and Lapps as demonstrated by various methods.
    Tittinen H; Mattila MJ; Eriksson AW
    Am Rev Respir Dis; 1973 Aug; 108(2):375-8. PubMed ID: 4720700
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood and urine INH levels, administered orally alone or combined with proteolytic enzymes].
    Concina E; Penna R; Grattarola M; Spataro C
    G Mal Infett Parassit; 1967 Jul; 19(7):450-1. PubMed ID: 5609921
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of pregnancy on the distribution of INH in rats].
    Danysz A; Jakimowska-Dudzińska K; Desperak-naciazek A
    Acta Physiol Pol; 1972; 23(4):697-701. PubMed ID: 5080268
    [No Abstract]   [Full Text] [Related]  

  • 17. [Change in isoniazid-H3 concentration in the blood and tissues in relation to dosage and mode of administration].
    Bondarev IM; Azhipa IaI; Cherednichenko LP
    Biull Eksp Biol Med; 1970 Oct; 70(10):31-4. PubMed ID: 5493115
    [No Abstract]   [Full Text] [Related]  

  • 18. [The pharmacokinetics of isoniazid in children (author's transl)].
    Advenier C; Saint-Aubin A; Scheinmann P; Paupe J
    Rev Fr Mal Respir; 1981; 9(5):365-74. PubMed ID: 7323401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of isoniazid metabolism in genetic studies. Anomalies encountered in trisomy 21 patients].
    Turpin R; Bergogne-Berezin E; Caille B; Salmon-Bonnereau D
    Ann Med Interne (Paris); 1969 Apr; 120(4):243-51. PubMed ID: 5356278
    [No Abstract]   [Full Text] [Related]  

  • 20. [Investigations into the polymorphism of acetylation of isonicotinic acid hydrazid (INH)].
    Goedde HW; Schloot W
    Med Welt; 1968 Dec; 51():2812-21. PubMed ID: 5752425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.